Payden & Rygel’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
Payden & Rygel's ABT Position: Q2 2024 in Review
Payden & Rygel sold out of Abbott (ABT) in Q2 2024, closing a stake of 133,500 shares — an estimated $15.2M sold.
Payden & Rygel first reported a position in ABT in Q4 2015 and held it in 16 quarters. The position peaked at $39.4M in Q4 2021. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.
- Payden & Rygel reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
- Payden & Rygel sold 133,500 Abbott shares in Q2 2024, an estimated $15.2M.
- Payden & Rygel first reported a position in Abbott in Q4 2015 and held it in 16 quarters.
- Payden & Rygel's Abbott position peaked at $39.4M in Q4 2021.
- 2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.
Based on Payden & Rygel's 13F filing for Q2 2024, filed 7 Oct 2024.